Remove Diabetes Remove Immunity Remove Vaccines
article thumbnail

Chikungunya vaccine approved for select groups by CDC advisory panel

STAT

In a global first, some travelers and laboratory researchers who are at risk of contracting chikungunya will soon be allowed to be vaccinated against the virus. A committee of vaccine experts recommended Wednesday that those selective groups of people should be offered access to the new vaccine, Ixchiq, which is made by Valneva Austria GmbH.

Vaccines 276
article thumbnail

Study finds air pollution lowers Covid vaccine response

Express Pharma

People exposed to higher levels of air pollution before the pandemic had lower antibody responses to COVID-19 vaccines, according to a study. The findings, published in the journal Environmental Health Perspectives , provide further evidence on the adverse effects of air pollution on the immune system. Exposure to PM2.5,

Vaccines 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

mRNA licensing agreements rise 800% in value as confidence grows beyond vaccines

Express Pharma

Messenger ribonucleic acid (mRNA)-based innovator pharmaceuticals saw a staggering 800 per cent increase in licensing agreement deal values from 2019 to 2024YTD, driven by the remarkable success of mRNA vaccines during the COVID-19 pandemic. billion in 2030. Bristol Myers Squibb formed a multi-year, $1.87

Vaccines 104
article thumbnail

Latest WHO Covid-19 vaccine guidance may decrease future demand

Pharmaceutical Technology

The World Health Organisation (WHO) has revised its recommendations regarding the use of Covid-19 vaccines following a meeting of the agency’s Strategic Advisory Group of Experts on Immunisation (SAGE). The panel emphasised that the extra booster dose recommendation only pertains to one shot and is not for continued annual booster vaccines.

Vaccines 111
article thumbnail

GSK launches shingles vaccine, Shingrix in India

Express Pharma

GlaxoSmithKline Pharmaceuticals (GSK) announced the launch of Shingrix (Zoster Vaccine Recombinant, Adjuvanted) in India, for the prevention of shingles (herpes zoster) and post-herpetic neuralgia in adults aged 50 years and above. Shingrix is a non-live, recombinant subunit vaccine to be given intramuscularly in two doses.

article thumbnail

US FDA approves GSK’s Arexvy, world’s first RSV vaccine for older adults

Express Pharma

GSK announced that the US Food and Drug Administration (FDA) has approved Arexvy (respiratory syncytial virus vaccine, adjuvanted) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. per cent (96.95% CI, 57.9–94.1, per cent (95% CI, 62.4–99.9,

article thumbnail

The RSV Vaccine: Everything You Need to Know

Community Pharmacy

While most healthy adults can shake off the adverse effects within a few days or weeks with mild cold systems, there are real risks for infants, the elderly, or anyone with a weakened immune system. Luckily, two new RSV vaccines have been developed and approved to help combat this risk and will be available this fall. What is RSV?